Reuters: Health
AstraZeneca said on Wednesday that the U.S. Food and Drug Administration has granted orphan drug status to its severe asthma drug, Fasenra, to treat eosinophilic oesophagitis (EoE).
U.S. FDA grants orphan drug status to AstraZeneca's asthma drug Fasenra
U.S. FDA grants orphan drug status to AstraZeneca's asthma drug Fasenra
Reuters: Health
AstraZeneca said on Wednesday that the U.S. Food and Drug Administration has granted orphan drug status to its severe asthma drug, Fasenra, to treat eosinophilic oesophagitis (EoE).
Reuters: Health
AstraZeneca said on Wednesday that the U.S. Food and Drug Administration has granted orphan drug status to its severe asthma drug, Fasenra, to treat eosinophilic oesophagitis (EoE).
Subscribe to:
Post Comments (Atom)
Popular Posts
|
No comments:
Post a Comment